CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 32,000 shares at $0.79 ($25,213)
- 4 Open-market buy COO/CFO bought 200,000 shares at $0.56 ($112,880)
- 4 Grant or award COO/CFO acquired 54,020 shares (grant or award)
- 4 Grant or award President & CEO acquired 540,176 shares (grant or award)
- 4 Grant or award EVP, Tech Ops and Admin acquired 13,504 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 1,814 shares at $1.29 ($2,340)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy COO/CFO bought 55,000 shares at $1.02 ($56,095)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 12 · 228 filings